Remimazolam clinical trials

Explore recruiting remimazolam clinical trials.

Recruiting remimazolam studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Remimazolam trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

The sedative effects and local tolerability of nasal administration of remimazolam using a Soft Mist Nasal Administration Device

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Efficacy and safety of Remimazolam compared to Ketamine and Propofol in Rapid Sequence Induction. A monocentric pilot randomised-controlled study

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Remimazolam versus Midazolam for sedation during upper GI endoscopy: a randomized controlled trial

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Efficacy, Safety, and Patient Satisfaction of Patient-Controlled Remimazolam Sedation in Outpatient Colonoscopy: A randomized controlled trial.

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Efficacy of Remimazolam with Fentanyl versus Midazolam with Fentanyl for sedation in screening colonoscopy: A randomized controlled study

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Remimazolam versus propofol for deep sedation during Endoscopic Ultrasound (EUS) procedures. A randomized controlled trial.

Italy

Therapeutic use (Phase IV) EU CTIS Study details

Remimazolam trials by city

Remimazolam in Toronto Remimazolam in Vancouver Remimazolam in Montreal Remimazolam in Calgary Remimazolam in Edmonton Remimazolam in Ottawa Remimazolam in Winnipeg Remimazolam in Quebec City Remimazolam in Hamilton Remimazolam in Kitchener Remimazolam in London Remimazolam in Halifax Remimazolam in New York Remimazolam in Los Angeles Remimazolam in Chicago Remimazolam in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease